Advertisement
U.S. markets closed

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
5.09+0.03 (+0.59%)
At close: 04:00PM EDT
5.09 0.00 (0.00%)
After hours: 05:13PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/29/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
417.13M764.23M536.78M661.71M688.42M721.93M
Enterprise Value
273.37M613.20M381.96M508.24M544.80M572.77M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/AN/A
Price/Book (mrq)
3.085.393.664.565.095.07
Enterprise Value/Revenue
N/AN/AN/AN/AN/AN/A
Enterprise Value/EBITDA
-6.44-54.30-37.41-45.22-38.40-37.29

Trading Information

Stock Price History

Beta (5Y Monthly) 0.58
52-Week Change 3-40.61%
S&P500 52-Week Change 327.86%
52 Week High 310.45
52 Week Low 34.48
50-Day Moving Average 35.50
200-Day Moving Average 36.94

Share Statistics

Avg Vol (3 month) 31.49M
Avg Vol (10 day) 31.75M
Shares Outstanding 582.11M
Implied Shares Outstanding 682.11M
Float 879.52M
% Held by Insiders 13.14%
% Held by Institutions 132.06%
Shares Short (Mar 15, 2024) 420M
Short Ratio (Mar 15, 2024) 413.62
Short % of Float (Mar 15, 2024) 425.16%
Short % of Shares Outstanding (Mar 15, 2024) 424.36%
Shares Short (prior month Feb 15, 2024) 419.89M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Oct 07, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-20.70%
Return on Equity (ttm)-31.88%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-43.16M
Diluted EPS (ttm)-0.54
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)143.76M
Total Cash Per Share (mrq)1.75
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)11.85
Book Value Per Share (mrq)1.65

Cash Flow Statement

Operating Cash Flow (ttm)-29.31M
Levered Free Cash Flow (ttm)-17.68M